FIELD: medicine, cardiology, pharmacy.
SUBSTANCE: invention relates to medicaments, namely, to using 2-[1-(1,1-dioxothietanyl-3)-benzimidazolyl-2-tho]acetic acid potassium salt of the formula: 
as a substance enhancing resistance of cardiac muscle against ischemia. Invention provides the stable cardioprotective effect in myocardium ischemia as compared with prototype (preparation obsidan).
EFFECT: enhanced effectiveness and valuable medicinal properties of agent.
4 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATMENT OF PATIENT WITH HEART ISCHEMIC DISEASE | 1998 |
|
RU2155036C2 |
| AGENT ELICITING ANTI-ISCHEMIC, HYPOTENSIVE, ANTI- -ARRHYTHMIC AND NOOTROPIC ACTIVITY | 2002 |
|
RU2216322C1 |
| METHOD FOR DIAGNOSING OPENING OF THE CORONARY ARTERY IN ACUTE MYOCARDIAL INFARCTION PATIENTS | 1999 |
|
RU2189173C2 |
| METHOD FOR PREVENTING AND TREATING MYOCARDIAL ISCHEMIA | 2002 |
|
RU2241463C2 |
| METHOD OF ACUTE MYOCARDIAL INFARCTION TREATMENT | 2008 |
|
RU2365380C1 |
| METHOD OF CARDIOPROTECTION OF ISCHEMIC AND REPERFUSION INJURIES IN ACUTE MYOCARDIAL INFARCTION | 2019 |
|
RU2712448C1 |
| METHOD FOR APPLYING REPERFUSION THERAPY TO ACUTE MYOCARDIAL INFARCTION PATIENTS | 2002 |
|
RU2226097C2 |
| METHOD OF TREATMENT OF ACUTE MYOCARDIAL ISCHEMIA | 0 |
|
SU1186213A1 |
| 2-MERCAPTOBENZIMIDAZOLE DERIVATIVES SHOWING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND ANTIFIBRILLATORY ACTIVITY | 1995 |
|
RU2136667C1 |
| APPLICATION OF GHRP-6 AS A CARDIOPROTECTIVE AND CARDIORESTORATIVE MEDICINAL PRODUCT FOR LATE TREATMENT | 2019 |
|
RU2779835C1 |
